Abstract
The world faces difficulties in terms of eye care, including treatment, quality of prevention, vision rehabilitation services, and scarcity of trained eye care experts. Early detection and diagnosis of ocular pathologies would enable forestall of visual impairment. One challenge that limits the adoption of computer-aided diagnosis tool by ophthalmologists is the number of sight-threatening rare pathologies, such as central retinal artery occlusion or anterior ischemic optic neuropathy, and others are usually ignored. In the past two decades, many publicly available datasets of color fundus images have been collected with a primary focus on diabetic retinopathy, glaucoma, age-related macular degeneration and few other frequent pathologies. To enable development of methods for automatic ocular disease classification of frequent diseases along with the rare pathologies, we have created a new Retinal Fundus Multi-disease Image Dataset (RFMiD). It consists of 3200 fundus images captured using three different fundus cameras with 46 conditions annotated through adjudicated consensus of two senior retinal experts. To the best of our knowledge, our dataset, RFMiD, is the only publicly available dataset that constitutes such a wide variety of diseases that appear in routine clinical settings. This dataset will enable the development of generalizable models for retinal screening.
Highlights
Most of the patients were subjected to mydriasis with one drop of tropicamide at 0.5%
The Retinal Fundus Multi-disease Image Dataset (RFMiD) is a new publicly available retinal images dataset consisting of 3200 images along with the expert annotations divided into two categories, as follows:
The dataset is split into 3 subsets: training 60% (1920 images), evaluation 20% (640 images), and test 20% (640 images) sets
Summary
Samiksha Pachade 1, * , Prasanna Porwal 1 , Dhanshree Thulkar 2 , Manesh Kokare 1 , Girish Deshmukh 3 , Vivek Sahasrabuddhe 4 , Luca Giancardo 5 , Gwenolé Quellec 6 and Fabrice Mériaudeau 7.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.